169 related articles for article (PubMed ID: 10836724)
1. Acute effects of a single low oral dose of pimobendan on left ventricular systolic and diastolic function in patients with congestive heart failure.
Ishiki R; Ishihara T; Izawa H; Nagata K; Hirai M; Yokota M
J Cardiovasc Pharmacol; 2000 Jun; 35(6):897-905. PubMed ID: 10836724
[TBL] [Abstract][Full Text] [Related]
2. Disparate inotropic and lusitropic responses to pimobendan in conscious dogs with tachycardia-induced heart failure.
Asanoi H; Ishizaka S; Kameyama T; Ishise H; Sasayama S
J Cardiovasc Pharmacol; 1994 Feb; 23(2):268-74. PubMed ID: 7511757
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of levosimendan, pimobendan, and milrinone on canine left ventricular-arterial coupling and mechanical efficiency.
Pagel PS; Hettrick DA; Warltier DC
Basic Res Cardiol; 1996; 91(4):296-307. PubMed ID: 8874779
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic, neurohumoral, and myocardial energetic effects of pimobendan, a novel calcium-sensitizing compound, in patients with mild to moderate heart failure.
Remme WJ; Kruijssen DA; van Hoogenhuyze DC; Krauss XH; Bartels GL; Storm CJ; de Leeuw PW
J Cardiovasc Pharmacol; 1994 Nov; 24(5):730-9. PubMed ID: 7532750
[TBL] [Abstract][Full Text] [Related]
5. Effects of pimobendan (UD-CG 115 BS) on left ventricular inotropic state in conscious dogs and in patients with heart failure.
Pouleur H; Hanet C; Schröder E; Col J; Van Mechelen H; Etienne J; Rousseau MF
J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S18-22. PubMed ID: 2478787
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of enantiomers of pimobendan in patients with dilated cardiomyopathy and congestive heart failure after single and repeated oral dosing.
Chu KM; Shieh SM; Hu OY
Clin Pharmacol Ther; 1995 Jun; 57(6):610-21. PubMed ID: 7781260
[TBL] [Abstract][Full Text] [Related]
7. Effects of MCI-154, a calcium sensitizer, on left ventricular systolic and diastolic function in pacing-induced heart failure in the dog.
Teramura S; Yamakado T; Maeda M; Nakano T
Circulation; 1997 Feb; 95(3):732-9. PubMed ID: 9024164
[TBL] [Abstract][Full Text] [Related]
8. Disparate force-frequency effects of pimobendan and dobutamine in conscious dogs with tachycardia-induced cardiomyopathy.
Joho S; Asanoi H; Ishizaka S; Kameyama T; Inoue H
J Card Fail; 2002 Dec; 8(6):423-30. PubMed ID: 12528096
[TBL] [Abstract][Full Text] [Related]
9. The cardiac effects of pimobendan (but not amrinone) are preserved at rest and during exercise in conscious dogs with pacing-induced heart failure.
Ohte N; Cheng CP; Suzuki M; Little WC
J Pharmacol Exp Ther; 1997 Jul; 282(1):23-31. PubMed ID: 9223536
[TBL] [Abstract][Full Text] [Related]
10. Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs.
Pagel PS; Harkin CP; Hettrick DA; Warltier DC
Anesthesiology; 1994 Oct; 81(4):974-87. PubMed ID: 7943849
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effects of intravenous pimobendan in patients with left ventricular dysfunction.
Remme WJ; Wiesfeld AC; Look MP; Kruyssen HA
J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S41-4. PubMed ID: 2478791
[TBL] [Abstract][Full Text] [Related]
12. A multicenter, randomized, double-blind, placebo-controlled trial of pimobendan, a new cardiotonic and vasodilator agent, in patients with severe congestive heart failure.
Katz SD; Kubo SH; Jessup M; Brozena S; Troha JM; Wahl J; Cohn JN; Sonnenblick EH; LeJemtel TH
Am Heart J; 1992 Jan; 123(1):95-103. PubMed ID: 1729854
[TBL] [Abstract][Full Text] [Related]
13. Effects of pimobendan on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy: comparison with nitroprusside.
Hasenfuss G; Holubarsch C; Heiss HW; Allgeier M; Just H
J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S31-5. PubMed ID: 2478789
[TBL] [Abstract][Full Text] [Related]
14. Effect of intravenous pimobendan (UDCG 115 BS) on hemodynamics and left ventricular volumes in idiopathic dilative cardiomyopathy.
Permanetter B; Sebening H; Hartmann F; Baumann G; Lutilsky L
J Cardiovasc Pharmacol; 1989 Dec; 14(6):803-9. PubMed ID: 2481765
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic profile of the cardiotonic agent pimobendan.
van Meel JC; Diederen W
J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S1-6. PubMed ID: 2478784
[TBL] [Abstract][Full Text] [Related]
16. [Reduction in left ventricular volume and improvement in hemodynamics following intravenous administration of pimobendan (UDGG 115 BS) in dilated cardiomyopathy].
Permanetter B; Sebening H; Busch U; Lutilsky L
Z Kardiol; 1990 Aug; 79(8):565-72. PubMed ID: 2220013
[TBL] [Abstract][Full Text] [Related]
17. Amrinone enhances myocardial contractility and improves left ventricular diastolic function in conscious and anesthetized chronically instrumented dogs.
Pagel PS; Hettrick DA; Warltier DC
Anesthesiology; 1993 Oct; 79(4):753-65. PubMed ID: 8214755
[TBL] [Abstract][Full Text] [Related]
18. Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs.
Harkin CP; Pagel PS; Tessmer JP; Warltier DC
J Cardiovasc Pharmacol; 1995 Aug; 26(2):179-88. PubMed ID: 7475041
[TBL] [Abstract][Full Text] [Related]
19. Levosimendan enhances left ventricular systolic and diastolic function in conscious dogs with pacing-induced cardiomyopathy.
Pagel PS; McGough MF; Hettrick DA; Lowe D; Tessmer JP; Jamali IN; Warltier DC
J Cardiovasc Pharmacol; 1997 May; 29(5):563-73. PubMed ID: 9213196
[TBL] [Abstract][Full Text] [Related]
20. Effects of low-dose flosequinan on left ventricular systolic and diastolic chamber performance.
Starling MR
Am Heart J; 1994 Jul; 128(1):124-33. PubMed ID: 8017265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
